ArticleDermatology and therapy2026

A Phase 3, Long-Term, Open-Label Study of Difamilast Ointment to Evaluate Efficacy and Safety in Japanese Infants with Atopic Dermatitis.

Hidehisa Saeki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.